Evidence map›Paper›PMID 42539908›Full record

ArticleSkin health and disease2026

When a haematoma is not a haematoma.

Johannes Woltsche, Isabella Fried, Angelika Kogler, Lorenzo Cerroni, Peter Wolf, Wolfgang Salmhofer

Abstract readCase Reports
In one paragraph

Article in Skin health and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Johannes WoltscheDepartment of Dermatology and Venereology, Medical University of Graz, Graz, Austria.ORCID https://orcid.org/0000-0002-2240-6736
Isabella FriedDepartment of Dermatology and Venereology, Medical University of Graz, Graz, Austria.
Angelika KoglerDepartment of Dermatology and Venereology, Medical University of Graz, Graz, Austria.
Lorenzo CerroniDepartment of Dermatology and Venereology, Medical University of Graz, Graz, Austria.
Peter WolfDepartment of Dermatology and Venereology, Medical University of Graz, Graz, Austria.
Wolfgang SalmhoferDepartment of Dermatology and Venereology, Medical University of Graz, Graz, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous angiosarcoma (cAS) is a rare but highly aggressive vascular malignancy, often associated with chronic lymphoedema or previous radiotherapy. Its nonspecific clinical presentation can mimic benign conditions, leading to diagnostic delays. We report the case of a 70-year-old woman with chronic lymphoedema of the right arm following mastectomy and lymphadenectomy for breast cancer. She presented with a slowly enlarging haematoma-like lesion. Magnetic resonance imaging (MRI) performed externally suggested a benign haematoma. Due to progressive changes, the patient was referred to our department. High-resolution sonography revealed irregular dermal and subcutaneous vasculature with marked hyperperfusion. Deep skin biopsy demonstrated a vascular neoplasm composed of pleomorphic endothelial cells expressing ERG, CD31, D2-40 and c-Myc, with a high Ki-67 proliferation index, consistent with the diagnosis of cAS (Stewart-Treves syndrome). Computed tomography staging excluded metastatic disease, and systemic paclitaxel therapy was initiated. This case underlines the often inconspicuous clinical presentation of cAS and the limited diagnostic value of MRI for superficial lesions. High-resolution sonography may provide an important, noninvasive diagnostic clue by revealing marked hypervascularity, thereby prompting timely biopsy and improving early detection of this aggressive tumour.

Identifiers

PMID42539908
PMCPMC13424889

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.